Chronic kidney disease in patients with the Philadelphia-negative chronic myeloproliferative neoplasms

被引:37
|
作者
Christensen, Alexander Sidelmann [1 ]
Moller, Jonas Bech [2 ]
Hasselbalch, Hans Carl [1 ]
机构
[1] Univ Copenhagen, Roskilde Hosp, Dept Hematol, Roskilde, Denmark
[2] Novo Nordisk AS, Quantitat Clin Pharmacol, Soborg, Denmark
关键词
Myeloproliferative neoplasms; Essential thrombocythemia; Polycythemia vera; Myelofibrosis; Chronic kidney disease; Chronic inflammation; Hydroxyurea; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; CHRONIC INFLAMMATION; PREVALENCE; THROMBOSIS; DISORDERS; CYTOKINES; MORTALITY; SCLEROSIS;
D O I
10.1016/j.leukres.2014.01.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The progression of kidney function and frequency of chronic kidney disease (CKD) in patients with the Philadelphia-negative myeloproliferative neoplasms (MPN) is unknown, although CKD is linked to increased mortality. Methods: This longitudinal retrospective study evaluates the estimated glomerular filtration rate (eGFR) in 143 MPN patients over a period of 9 years. Results: 29% of patients had CKD stage 3 or 4 at time of diagnosis. 20% of patients had a rapid annual loss of eGFR (>3 mL/min/1.73 m(2)) and eGFR was negatively correlated to monocyte and neutrophil counts. Conclusion: Kidney impairment might contribute to the increased mortality observed in MPN patients. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:490 / 495
页数:6
相关论文
共 50 条
  • [21] Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms
    Perez, Cristina
    Pascual, Marien
    Ignacio Martin-Subero, Jose
    Bellosillo, Beatriz
    Segura, Victor
    Delabesse, Eric
    Alvarez, Sara
    Jose Larrayoz, Maria
    Rifon, Jose
    Cruz Cigudosa, Juan
    Besses, Caries
    Jose Calasanz, Maria
    Cross, Nicholas C. P.
    Prosper, Felipe
    Agirre, Xabier
    HAEMATOLOGICA, 2013, 98 (09) : 1414 - 1420
  • [22] Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms
    Krecak, Ivan
    Peran, Nena
    Lapic, Ivana
    Gveric-Krecak, Velka
    Krecak, Filip
    Roncevic, Pavle
    Durakovic, Nadira
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (1-2) : 62 - 64
  • [23] Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms
    Ivan Krečak
    Nena Peran
    Ivana Lapić
    Velka Gverić-Krečak
    Filip Krečak
    Pavle Rončević
    Nadira Duraković
    Wiener klinische Wochenschrift, 2021, 133 : 62 - 64
  • [24] Inflammatory picture of Philadelphia-negative myeloproliferative neoplasms
    Barbosa Pagnano, Katia Borgia
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (02) : 101 - 102
  • [25] IMPORTANCE OF COAGULATION ASSESSMENT IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS PATIENTS
    Kabat, M. Gasior
    Pollmar, M. I. Rivas
    Roman, M. T. Alvarez
    Manzano, E. Monzon
    Butta, P. Acuna
    Salgado, E. G. Arias
    Salces, M. Martin
    Giulinai, M. Facal
    Marugan, P. Gonzalez
    De Bustamante, J. Martin
    Serrano, L. Gomez
    Barcenilla, S. Garcia
    Castro, C. Ramos
    Coll, N. Butta
    Yuste, V. Jimenez
    HAEMOPHILIA, 2023, 29 : 166 - 166
  • [26] Molecular characterization of Philadelphia-negative myeloproliferative neoplasms
    Brisci, Angela
    Pietra, Daniela
    Foglieni, Barbara
    Boggi, Sabrina
    Rumi, Elisa
    Passamonti, Francesco
    Ferrari, Maurizio
    Cremonesi, Laura
    BIOCHIMICA CLINICA, 2010, 34 (02) : 110 - 114
  • [27] Allogeneic stem cell transplantation in Philadelphia-negative chronic myeloproliferative neoplasms. A centre experience
    Avendano Pita, Alejandro
    Carrillo Checa, Javier
    Rivera Delgado, Daniel
    Vaz Alvaro, Veiga
    Zalacain Nerea, Arratibel
    Gonzalez Monica, Baile
    Lopez Cadenas, Felix
    Lopez Estefania, Perez
    Lopez Corral, Lucia
    Calvo Monica, Cabrero
    Gonzalez Porras, Jose Ramon
    Caballero Barrigon, Maria Dolores
    Martin Lopez, Ana Africa
    BONE MARROW TRANSPLANTATION, 2018, 53 : 242 - 243
  • [28] Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives
    Hasselbalch, Hans Carl
    Larsen, Thomas Stauffer
    Riley, Caroline Hasselbalch
    Jensen, Morten Krogh
    Kiladjian, Jean-Jacques
    CURRENT DRUG TARGETS, 2011, 12 (03) : 392 - 419
  • [29] Spleen and Liver Fibrosis Is Associated to Treatment Response and Prognosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms
    Auteri, Giuseppe
    Sansone, Vito
    Bartoletti, Daniela
    Di Pietro, Christian
    Sutto, Emanuele
    Mazzoni, Camilla
    Vianelli, Nicola
    Cavo, Michele
    Piscaglia, Fabio
    Palandri, Francesca
    BLOOD, 2021, 138
  • [30] Allogeneic Stem Cell Transplantation in Philadelphia-Negative Chronic Myeloproliferative Neoplasms. A Center Experience
    Avendano Pita, Alejandro
    Carrillo Checa, Javier
    Rivera Delgado, Daniel
    Veiga Vaz, Alvaro
    Arratibel Zalacain, Nerea
    Baile Gonzalez, Monica
    Lopex Cadenas, Felix
    Perez Lopez, Estefania
    Lopez Corral, Lucia
    Cabrero Calvo, Monica
    Gonzalez Porras, Jose Ramon
    Caballero Barrigon, Ma Dolores
    Martin Lopez, Ana Africa
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S307 - S308